China growth continues for CMPi
CPhI China, which together with ICSE and P-MEC will take place in Shanghai's New International Expo Centre (SNIEC) from 24-26 June 2008, is expected to show continued growth on previous years.
CPhI China, which together with ICSE and P-MEC will take place in Shanghai's New International Expo Centre (SNIEC) from 24-26 June 2008, is expected to show continued growth on previous years.
The three exhibitions are being staged across six halls and two tents, with nearly 1,400 combined exhibitors from 20 countries presenting to more than 19,000 expected attendees.
Organiser CMPi is forecasting further year-on-year growth for the events - reflecting the massive expansion of China's role and recognised importance in serving the global pharma community.
Just three years ago total exhibitors numbered fewer than 800. P-MEC China only joined the family in 2006, yet this year is taking more than 7,000m2 of space for nearly 250 exhibitors in the machinery and equipment segment.
P-MEC reflects a growing emphasis on production systems and technologies as the pharma ingredients production industry looks to meet and balance the many complex challenges in compliance, cost and environmental footprint.
Capturing and managing the expanding opportunities to do business in China is a key theme in the second CPhI China International Forum, returning after its successful 2007 debut. The Forum is again co-organised by CMPi and the China markets trading consultancy Pacific Genuity Inc. The twin tracks of Pharmaceutical Manufacturing Excellence and Global Sourcing from China are complemented by c-GMP Workshop and Training sessions.
"Our events package, and its rapid year-on-year growth, reflects the continuing momentum of China's role in the global pharma community," said CPhI Event Director Annemieke Timmers. "Partnership opportunities for both Western and Chinese companies are expanding rapidly, with our Shanghai events becoming increasingly important on the industry calendar."